Galderma Group AG (SWX:GALD)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
145.90
0.00 (0.00%)
At close: Feb 27, 2026
30.69%
Market Cap 34.64B
Revenue (ttm) 3.73B
Net Income (ttm) 300.62M
Shares Out 237.41M
EPS (ttm) 1.26
PE Ratio 115.41
Forward PE 45.66
Dividend 0.15 (0.10%)
Ex-Dividend Date n/a
Volume 691,727
Average Volume 374,817
Open 145.50
Previous Close 145.90
Day's Range 142.50 - 147.30
52-Week Range 72.70 - 170.10
Beta n/a
RSI 40.78
Earnings Date Mar 5, 2026

About Galderma Group AG

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes ACTINICA, Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, Mirvaso, NEMLUVIO, Relfydess, Benzac, Loceryl, and TRI-LUMA in therapeutic dermatology. ... [Read more]

Sector Healthcare
Founded 1981
Employees 6,545
Stock Exchange SIX Swiss Exchange
Ticker Symbol GALD
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.